Ouabagenin is a naturally occurring LXR ligand without causing hepatic steatosis as a side effect

Ouabagenin (OBG) is an aglycone of the cardiotonic steroid ouabain and until now was considered a biologically inactive biosynthetic precursor. Herein, we revealed that OBG functions as a novel class of ligand for the liver X receptor (LXR). Luciferase reporter assays and in silico docking studies suggested that OBG has LXR-selective agonistic activity. In addition, OBG repressed the expression of epithelial sodium channel (ENaC), a LXR target gene, without causing hepatic steatosis, a typical side effect of conventional LXR ligands. This remarkable biological activity can be attributed to a unique mode of action; the LXR agonist activity mainly proceeds through the LXRβ subtype without affecting LXRα, unlike conventional LXR ligands. Thus, OBG is a novel class of LXR ligand that does not cause severe side effects, with potential for use as an antihypertensive diuretic or a tool compound for exploring LXR subtype-specific biological functions.

• Publication year

  2018

• Venue

  Scientific Reports

• Publication date

  2018-02-02

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/s41598-018-20663-zPMID 29396543PMCID 5797171
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting liver X receptors in cancer therapeutics

  2015cited by this paper
• Oxysterols and EBI2 promote osteoclast precursor migration to bone surfaces and regulate bone mass homeostasis

  2015cited by this paper
• 7α-Hydroxycholesterol induces inflammation by enhancing production of chemokine (C-C motif) ligand 2.

  2015cited by this paper
• 22‐S‐Hydroxycholesterol protects against ethanol‐induced liver injury by blocking the auto/paracrine activation of MCP‐1 mediated by LXRα

  2015cited by this paper
• Epithelial sodium channel (ENaC) and the control of blood pressure.

  2014cited by this paper
• Blood pressure and amiloride-sensitive sodium channels in vascular and renal cells

  2014cited by this paper
• Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis

  2014cited by this paper
• Liver X receptors in lipid metabolism: opportunities for drug discovery

  2014cited by this paper
• Oxysterols induce mitochondrial impairment and hepatocellular toxicity in non-alcoholic fatty liver disease.

  2014cited by this paper
• Action mechanisms of Liver X Receptors.

  2014cited by this paper
• Oxysterols in the orchestra of liver cell metabolism.

  2014cited by this paper
• The oxysterol receptors lxrα and lxrβ suppress proliferation in the colon

  2013cited by this paper
• Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR

  2012cited by this paper
• Liver X receptor agonists decrease ENaC-mediated sodium transport in collecting duct cells.

  2012cited by this paper
• Selective liver X receptor modulators (SLiMs): what use in human health?

  2012cited by this paper
• LXRβ activation increases intestinal cholesterol absorption, leading to an atherogenic lipoprotein profile

  2012cited by this paper
• TO901317 regulating apolipoprotein M expression mediates via the farnesoid X receptor pathway in Caco-2 cells

  2011cited by this paper
• Activation of liver X receptor-α reduces activation of the renal and cardiac renin–angiotensin–aldosterone system

  2010cited by this paper
• Signaling mechanisms that link salt retention to hypertension: endogenous ouabain, the Na(+) pump, the Na(+)/Ca(2+) exchanger and TRPC proteins.

  2010cited by this paper
• GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRbeta in the hepatic acute phase response.

  2010cited by this paper
• Liver X receptor modulators: a review of recently patented compounds (2007 – 2009)

  2010cited by this paper
• Design and synthesis of phthalimide-based fluorescent liver x receptor antagonists.

  2010cited by this paper
• Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics.

  2010cited by this paper
• Non-redundant roles for LXRalpha and LXRbeta in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice.

  2010cited by this paper
• Minireview: liver X receptor beta: emerging roles in physiology and diseases.

  2009cited by this paper
• Crystal structure of the sodium-potassium pump with bound potassium and ouabain

  2009cited by this paper
• The Pump, the Exchanger, and Endogenous Ouabain: Signaling Mechanisms That Link Salt Retention to Hypertension

  2009cited by this paper
• Crystal structure of the sodium-potassium pump (Na+,K+-ATPase) with bound potassium and ouabain

  2009cited by this paper
• Biological role of liver X receptors.

  2008cited by this paper
• Opportunities for Drug Discovery: Targeting Fungal Cell Walls

  2007cited by this paper
• GW3965, a synthetic liver X receptor (LXR) agonist, reduces angiotensin II‐mediated pressor responses in Sprague–Dawley rats

  2007cited by this paper
• Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma.

  2007cited by this paper
• The Na,K-ATPase receptor complex

  2007cited by this paper
• Sensors and Signals: a Coactivator/ Corepressor/epigenetic Code for Integrating Signal-dependent Programs of Transcriptional Response

  2006cited by this paper
• Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response.

  2006cited by this paper
• Functional domains of the epithelial sodium channel.

  2005cited by this paper
• Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition.

  2005cited by this paper
• Principles for modulation of the nuclear receptor superfamily

  2004cited by this paper
• T0901317 is a dual LXR/FXR agonist.

  2004cited by this paper
• Na+-K+--ATPase-mediated signal transduction: from protein interaction to cellular function.

  2003cited by this paper
• Crystal structure of the heterodimeric complex of LXRα and RXRβ ligand‐binding domains in a fully agonistic conformation

  2003cited by this paper
• Antidiabetic Action of a Liver X Receptor Agonist Mediated By Inhibition of Hepatic Gluconeogenesis*

  2003cited by this paper
• The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse Published, JLR Papers in Press, August 16, 2003. DOI 10.1194/jlr.M300135-JLR200

  2003cited by this paper
• The Three-dimensional Structure of the Liver X Receptor β Reveals a Flexible Ligand-binding Pocket That Can Accommodate Fundamentally Different Ligands*

  2003cited by this paper
• Direct and Indirect Mechanisms for Regulation of Fatty Acid Synthase Gene Expression by Liver X Receptors*

  2002cited by this paper
• Stimulation of Lipogenesis by Pharmacological Activation of the Liver X Receptor Leads to Production of Large, Triglyceride-rich Very Low Density Lipoprotein Particles*

  2002cited by this paper
• Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice.

  2001cited by this paper
• Identification of Liver X Receptor-Retinoid X Receptor as an Activator of the Sterol Regulatory Element-Binding Protein 1c Gene Promoter

  2001cited by this paper
• The role of orphan nuclear receptors in the regulation of cholesterol homeostasis.

  2000cited by this paper
• Cholestenoic acid is a naturally occurring ligand for liver X receptor alpha.

  2000cited by this paper
• Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ

  2000cited by this paper
• Cholestenoic Acid Is a Naturally Occurring Ligand for Liver X Receptor α* * This work was supported by NIH grants.

  2000cited by this paper
• Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta.

  2000cited by this paper
• Role of LXRs in control of lipogenesis.

  2000cited by this paper
• Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta.

  1999cited by this paper
• Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha.

  1998cited by this paper
• The LXRs: a new class of oxysterol receptors.

  1998cited by this paper
• The heterotetrameric architecture of the epithelial sodium channel (ENaC)

  1998cited by this paper
• Cholesterol and Bile Acid Metabolism Are Impaired in Mice Lacking the Nuclear Oxysterol Receptor LXRα

  1998cited by this paper
• Structure and specificity of nuclear receptor-coactivator interactions.

  1998cited by this paper
• Activation of the Nuclear Receptor LXR by Oxysterols Defines a New Hormone Response Pathway*

  1997cited by this paper
• Identification of Amino Acid Residues in the α, β, and γ Subunits of the Epithelial Sodium Channel (ENaC) Involved in Amiloride Block and Ion Permeation

  1997cited by this paper
• Tissue Distribution and Quantification of the Expression of mRNAs of Peroxisome Proliferator–Activated Receptors and Liver X Receptor-α in Humans: No Alteration in Adipose Tissue of Obese and NIDDM Patients

  1997cited by this paper
• An oxysterol signalling pathway mediated by the nuclear receptor LXRα

  1996cited by this paper
• Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits

  1994cited by this paper
• Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus.

  1993cited by this paper
• The steroid receptor superfamily: more excitement predicted for the future.

  1990cited by this paper
• Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis.

  1977cited by this paper

• Liver X Receptors and the Hallmarks of Aging: From Molecular Mechanisms to Therapeutic Opportunities.

  2025cites this paper
• The Composition and Biochemical Properties of Strophantus (Apocynaceae), with a Focus on S. sarmentosus

  2024cites this paper
• Therapeutic effect of ouabagenin, a novel liver X receptor agonist, on atherosclerosis in nonalcoholic steatohepatitis in SHRSP5/Dmcr rat model.

  2023cites this paper
• Flindissone, a Limonoid Isolated from Trichilia prieuriana, Is an LXR Agonist

  2023cites this paper
• In Silico Pharmacokinetic Profiling of the Identified Bioactive Metabolites of Pergularia tomentosa L. Latex Extract and In Vitro Cytotoxic Activity via the Induction of Caspase-Dependent Apoptosis with S-Phase Arrest

  2022cites this paper
• The liver x receptor is selectively modulated to differentially alter female mammary metastasis-associated myeloid cells.

  2022cites this paper
• Nuclear Receptors and Lipid Sensing.

  2022cites this paper
• In Silico Prospects and Therapeutic Applications of Ouabagenin and Hydroxylated Corticosteroid Analogues in the Treatment of Lung Cancer

  2022cites this paper
• Fundamental Toxicological Sciences

  2021influential citation
• Contemporary advancements in the semi-synthesis of bioactive terpenoids and steroids.

  2021cites this paper
• Ouabagenin, an aglycone of cardiotonic steroid ouabain, functions as LXR ligand but avoids the increase in the SREBP-1 by inducing Krüppel-like factor 15

  2021cites this paper
• Liver X receptors conserve the therapeutic target potential for the treatment of Rheumatoid arthritis.

  2021cites this paper
• Cardiac Glycoside Ouabain Exerts Anticancer Activity via Downregulation of STAT3

  2021cites this paper
• Liver X receptors and Skeleton: Current state-of-knowledge.

  2020cites this paper
• Regulation of ATP binding cassette transporter A1 (ABCA1) expression: cholesterol-dependent and – independent signaling pathways with relevance to inflammatory lung disease

  2020cites this paper
• Natural cardenolides suppress coronaviral replication by downregulating JAK1 via a Na+/K+-ATPase independent proteolysis

  2020cites this paper
• Cardiac glycosides with target at direct and indirect interactions with nuclear receptors.

  2020cites this paper
• Identify liver X receptor β modulator building blocks by developing a fluorescence polarization-based competition assay.

  2019cites this paper